We are delighted to announce that the first Newsletter of the TransBioLine project is online!
This Newsletter summarizes the highlights of the scientific progress and the consortium activities during the first year of the project.

Don’t want to miss a thing about TransBioLine?

Subscribe to our newsletter now!

The TransBioLine project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA